Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Volkin

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Nature Biotechnology|March 22, 2022
Development of spirulina for the manufacture and oral delivery of protein therapeuticsBenjamin W Jester, Hui Zhao, Mesfin Gewe, et al.
Science Advances|March 16, 2022
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaquesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamstersNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Nature|January 18, 2002
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityJohn W Shiver, Tong-Ming Fu, Ling Chen, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Nature Biotechnology|March 22, 2022
Development of spirulina for the manufacture and oral delivery of protein therapeuticsBenjamin W Jester, Hui Zhao, Mesfin Gewe, et al.
Science Advances|March 16, 2022
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaquesNeil C Dalvie, Lisa H Tostanoski, Sergio A Rodriguez-Aponte, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamstersNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Nature|January 18, 2002
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunityJohn W Shiver, Tong-Ming Fu, Ling Chen, et al.
Pageof 18